Appraisal of typhoid vaccine in experimentally infected human subjects
about
Control of Invasive Salmonella Disease in Africa: Is There a Role for Human Challenge Models?Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005.Growth of typhoid and paratyphoid bacilli in intravenously infected mice.Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trialOral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid Disease.Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteersOral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease.Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animalsThe relationship between infecting dose and severity of disease in reported outbreaks of Salmonella infections.Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humansRelation between structure and immunologic properties of the Vi capsular polysaccharide.Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model.An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.A cross-sectional seroepidemiological survey of typhoid fever in Fiji.Vaccines and cell-mediated immunity.
P2860
Q26785760-51A873BE-4C72-469F-8F1C-A134AE9810D8Q31121277-585ABC82-4348-47D5-9538-648B418DCF62Q34502525-69BEB350-215D-43B1-B2EC-5CEDB863BC1CQ34673466-AE8E9E06-272F-493E-A48C-CA357E64B713Q35660952-3377395E-9CAE-480F-AC92-E42BD490371FQ35778973-535AEE8C-3219-424D-8303-4356297867EEQ36051755-191C863F-B48F-4A18-A88C-AC61CD86EC98Q36357539-66F6DBCE-98A9-403E-9512-FE5E29837B30Q36505378-876532F6-D683-47F0-8949-FCA18C6A3ECDQ36634226-D9BC9586-6C6F-4D20-A5A9-879A8ED3CA44Q36990350-81F72044-DA55-4D88-ACAC-17B7603D9A11Q37675513-CFCBA699-DDFA-49F9-91E4-12E1E5987C93Q37696581-90B41347-35BC-49D5-915B-9FF6F69FD666Q38670057-C6EB5206-40C2-4A3D-A3B5-39E9C02D167EQ39950952-B6FECBDB-8749-406C-898E-2E07ECA98555
P2860
Appraisal of typhoid vaccine in experimentally infected human subjects
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
1967年论文
@zh
1967年论文
@zh-cn
name
Appraisal of typhoid vaccine in experimentally infected human subjects
@ast
Appraisal of typhoid vaccine in experimentally infected human subjects
@en
type
label
Appraisal of typhoid vaccine in experimentally infected human subjects
@ast
Appraisal of typhoid vaccine in experimentally infected human subjects
@en
prefLabel
Appraisal of typhoid vaccine in experimentally infected human subjects
@ast
Appraisal of typhoid vaccine in experimentally infected human subjects
@en
P2860
P1476
Appraisal of typhoid vaccine in experimentally infected human subjects
@en
P2093
Hornick RB
Woodward TE
P2860
P577
1967-01-01T00:00:00Z